{"id":"https://openalex.org/W7125979239","doi":"https://doi.org/10.1136/bcr-2025-270094","title":"Use of intravenous immunoglobulin in combination with corticosteroids for immune checkpoint inhibitor pneumonitis","display_name":"Use of intravenous immunoglobulin in combination with corticosteroids for immune checkpoint inhibitor pneumonitis","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7125979239","doi":"https://doi.org/10.1136/bcr-2025-270094","pmid":"https://pubmed.ncbi.nlm.nih.gov/41605554"},"language":"en","primary_location":{"id":"doi:10.1136/bcr-2025-270094","doi":"https://doi.org/10.1136/bcr-2025-270094","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bcr-2025-270094","pdf_url":null,"source":{"id":"https://openalex.org/S141953298","display_name":"BMJ Case Reports","issn_l":"1757-790X","issn":["1757-790X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048940844","display_name":"Neha Puttagunta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Neha Puttagunta","raw_affiliation_strings":["Internal Medicine, Northwell Health, Manhasset, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Northwell Health, Manhasset, New York, USA","institution_ids":["https://openalex.org/I1302444339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124143998","display_name":"Saman Suleman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saman Suleman","raw_affiliation_strings":["Internal Medicine, Northwell Health, Manhasset, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Northwell Health, Manhasset, New York, USA","institution_ids":["https://openalex.org/I1302444339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007408126","display_name":"Divija Sharma","orcid":"https://orcid.org/0000-0002-2547-4160","observed_orcids":["https://orcid.org/0000-0002-2547-4160"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Divija Sharma","raw_affiliation_strings":["Internal Medicine, Northwell Health, Manhasset, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Northwell Health, Manhasset, New York, USA","institution_ids":["https://openalex.org/I1302444339"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035337775","display_name":"Syed Ejaz Ahmad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syed E Ahmad","raw_affiliation_strings":["Internal Medicine, Northwell Health, Manhasset, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Northwell Health, Manhasset, New York, USA","institution_ids":["https://openalex.org/I1302444339"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5048940844"],"corresponding_institution_ids":["https://openalex.org/I1302444339"],"apc_list":null,"apc_paid":null,"fwci":2.7418,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.85318668,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"19","issue":"1","first_page":"e270094","last_page":"e270094"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-pneumonitis","display_name":"immune checkpoint inhibitor pneumonitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.9480000138282776},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9279999732971191},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hypoxemic-respiratory-failure","display_name":"hypoxemic respiratory failure","score":0.8410000205039978},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.886900007724762},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8733000159263611},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.7936000227928162},{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.7782999873161316},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6549999713897705},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6341999769210815},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5231000185012817},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47110000252723694},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.42489999532699585},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3634999990463257},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.35749998688697815},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.3052999973297119},{"id":"https://openalex.org/C2909916134","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulin Therapy","level":3,"score":0.2937000095844269},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.27649998664855957},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.2759000062942505},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.2702000141143799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2581000030040741},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.2526000142097473}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1136/bcr-2025-270094","doi":"https://doi.org/10.1136/bcr-2025-270094","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bcr-2025-270094","pdf_url":null,"source":{"id":"https://openalex.org/S141953298","display_name":"BMJ Case Reports","issn_l":"1757-790X","issn":["1757-790X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Reports","raw_type":"journal-article"},{"id":"pmid:41605554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41605554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ case reports","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2168353850","https://openalex.org/W2522337762","https://openalex.org/W2786816161","https://openalex.org/W2948565764","https://openalex.org/W2958220850","https://openalex.org/W2978259912","https://openalex.org/W3120199795","https://openalex.org/W3120362667","https://openalex.org/W3129124969","https://openalex.org/W4390939891","https://openalex.org/W4391837910","https://openalex.org/W4393238295"],"related_works":["https://openalex.org/W2929968522","https://openalex.org/W7161588094","https://openalex.org/W4410809862","https://openalex.org/W4293767473","https://openalex.org/W4413272000","https://openalex.org/W3024879449","https://openalex.org/W7161543462","https://openalex.org/W2990764364","https://openalex.org/W7161565007","https://openalex.org/W4387248228"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitor":[2],"(ICI)":[3],"pneumonitis":[4,95],"is":[5,39],"a":[6,75,79,82],"potentially":[7],"life-threatening":[8],"immune-related":[9],"adverse":[10],"event":[11],"associated":[12],"with":[13,48,70,84,106],"ICI":[14,94],"therapy":[15],"across":[16],"various":[17],"malignancies.":[18],"ICIs":[19,57],"enhance":[20],"antitumour":[21],"immunity":[22],"by":[23],"targeting":[24],"inhibitory":[25],"cell":[26],"surface":[27],"receptors,":[28],"but":[29],"this":[30,130],"can":[31],"lead":[32],"to":[33],"immune-mediated":[34],"tissue":[35],"damage.":[36],"Prompt":[37],"recognition":[38],"critical,":[40],"as":[41],"symptoms":[42],"are":[43],"often":[44],"nonspecific":[45],"and":[46,58,89,96,110,135],"overlap":[47],"infectious":[49],"or":[50],"malignant":[51],"processes.Standard":[52],"treatment":[53],"involves":[54],"discontinuation":[55],"of":[56,60,65,81],"initiation":[59],"corticosteroids.":[61],"However,":[62],"optimal":[63],"management":[64],"steroid-refractory":[66],"cases":[67],"remains":[68],"unclear,":[69],"intravenous":[71],"immunoglobulin":[72],"(IVIG)":[73],"considered":[74],"second-line":[76],"option.We":[77],"present":[78],"case":[80],"patient":[83,103],"hepatocellular":[85],"carcinoma":[86],"on":[87],"durvalumab":[88],"tremelimumab":[90],"who":[91],"developed":[92],"severe":[93],"acute":[97],"hypoxic":[98],"respiratory":[99],"failure.":[100],"Notably,":[101],"the":[102,117,125],"was":[104],"treated":[105],"upfront":[107],"pulse-dose":[108],"corticosteroids":[109],"IVIG-a":[111],"combination":[112],"not":[113],"currently":[114],"described":[115],"in":[116],"literature.":[118],"The":[119],"patient's":[120],"rapid":[121],"clinical":[122],"improvement":[123],"without":[124],"need":[126],"for":[127],"intubation":[128],"suggests":[129],"approach":[131],"may":[132],"be":[133],"effective":[134],"warrants":[136],"further":[137],"investigation.":[138]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-01-29T00:00:00"}